✦ LIBER ✦

Evaluation of voice by patients and close relatives following different laryngeal cancer treatments

✍ Scribed by David E. Schuller; Michael Trudeau; Jane Bistline; Karen Laface

Publisher: John Wiley and Sons
Year: 1990
Tongue: English
Weight: 457 KB
Volume: 44
Category: Article
ISSN: 0022-4790
DOI: 10.1002/jso.2930440104

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Thermography in the follow-up of breast

Thermography in the follow-up of breast cancer patients after breast-conserving treatment by tumorectomy and radiation therapy

✍ Hans Ulrich Ulmer; Martina Brinkmann; Hans-Joachim Frischbier 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 433 KB 👁 2 views

Neoadjuvant radiochemotherapy of oral ca

Neoadjuvant radiochemotherapy of oral cavity and oropharyngeal cancer: evaluation of tumor response by ct differs from histopathologic response assessment in a significant fraction of patients

✍ Clemens Klug; David Keszthelyi; Oliver Ploder; Irene Sulzbacher; Martin Voracek; 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 463 KB 👁 1 views

## Abstract ## Background. Our aim was to compare and assess the predictive value of CT and histopathologic grading of tumor regression at primary tumor sites in patients with squamous cell carcinoma of the oral cavity and oropharynx after neoadjuvant (preoperative) radiochemotherapy (RCT). ## Me

Induction chemotherapy with cisplatin an

Induction chemotherapy with cisplatin and 5-fluorouracil followed by chemoradiotherapy or radiotherapy alone in the treatment of locoregionally advanced resectable cancers of the larynx and hypopharynx: Results of single-center study of 45 patients

✍ Ozden Altundag; Ibrahim Gullu; Kadri Altundag; Suayib Yalcin; Enis Ozyar; Mustaf 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 229 KB

Background. Induction chemotherapy with cisplatin and fluorouracil and radiotherapy is an effective alternative to surgery in patients with carcinoma of the larynx and hypopharynx who are treated for organ preservation. Methods. We designed a protocol to evaluate the possibility of organ preservati

Combination therapy with fludarabine and

Combination therapy with fludarabine and rituximab followed by alemtuzumab in the first-line treatment of patients with chronic lymphocytic leukemia or small lymphocytic lymphoma : A phase 2 trial of the Minnie Pearl Cancer Research Network

✍ John D. Hainsworth; Elizabeth R. Vazquez; David R. Spigel; Eric Raefsky; James D 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 106 KB 👁 2 views

## Abstract ## BACKGROUND The purpose of the current study was to evaluate the efficacy and toxicity of the combination of fludarabine and rituximab, followed by alemtuzumab, as first‐line treatment for patients with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL). ## METHO